| 1 | Genetics, Pathophysiology, and Current Challenges in Von Hippel-Lindau Disease Therapeutics | 2ᵒ autor: Velazquez-Paniagua, M, Gómez-Virgilio, L, Cuazozon-Ferrer, L, Silva-Lucero, MD, et al. | 2024 | Diagnostics | WoS-id: 001311077800001
Scopus-id: 2-s2.0-85203851044
| 0 | 0 |
| 2 | Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug | 2ᵒ autor: Velázquez-Paniagua M., Vásquez-Bochm L.X., Castro-Vázquez S.S., Guerrero-Rodríguez S.L., et al. | 2019 | PHARMACOLOGICAL REPORTS | WoS-id: 000468190600023
Scopus-id: 2-s2.0-85064538669
| 28 | 31 |
| 3 | Guide for Selection of Relevant Cell Lines During the Evaluation of new Anti-Cancer Compounds | Coautor: Velazquez-Paniagua, Mireya, Ruiz-Moreno, Angel J., Torres-Barrera, Patricia, Domling, Alexander, et al. | 2018 | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | WoS-id: 000454517900001
Scopus-id: 2-s2.0-85060365151
| 1 | 1 |
| 4 | MELATONIN APPLICATION ALTERS THE MALE WISTAR RAT'S FERTILITY | 1ᵉʳ autor: Paniagua, MV, Ruiz, JG, Vazquez, CR, Gomez, BP | 2011 | ACTA ENDOCRINOL-BUCH | WoS-id: 000298778900005
Scopus-id: 2-s2.0-84863631990
| 1 | 1 |
| 5 | Melatonin attenuates the decrement of dendritic protein MAP-2 immuno-staining in the hippocampal CA1 and CA3 fields of the aging male rat | 2ᵒ autor: Velazquez-Paniagua, M, Prieto-Gomez, B, Cisneros, LO, Reyes-Vazquez, C, et al. | 2008 | NEUROSCIENCE LETTERS | WoS-id: 000261553800013
Scopus-id: 2-s2.0-55749101336
| 19 | 20 |
| 6 | Melatonin's effects on free radical levels in rat hippocampus, measured by electronic paramagnetic resonance | 1ᵉʳ autor: Velázquez-Paniagua M., Contreras-Pérez R., Gómez-Vidales V., Meneses-Pérez M.A., et al. | 2007 | Pharmacologyonline | Scopus-id: 2-s2.0-34248369408
| 0 | 2 |
ID's SCOPUS 
ORCID's 